Displaying drugs 1 - 25 of 403 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Abaloparatide | 3961.0 C174H300N56O49 |  | A parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in patients with a high risk of fracture. | Bone Density Conservation Agents / Parathyroid Hormones and Analogues |
| Abatacept | 92300.0 C3498H5458N922O1090S32 | | A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease. | Selective Immunosuppressants |
| Abciximab | 145651.1 C6462H9964N1690O2049S48 |  | A monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention. | Platelet Aggregation Inhibitors Excl. Heparin |
| Adalimumab | 144190.3 C6428H9912N1694O1987S46 |  | A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Aducanumab | 146000.0 | | A monoclonal antibody indicated in the treatment of Alzheimer's disease. | Amyloid Beta-directed Antibodies |
| Aflibercept | 115000.0 C4318H6788N1164O1304S32 | | A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer | Antineovascularisation Agents |
| Agalsidase alfa | 45351.6 C2029H3080N544O587S27 |  | A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. | alpha-Galactosidase, antagonists & inhibitors / Enzymes / Galactosidases |
| Agalsidase beta | 45351.6 C2029H3080N544O587S27 |  | A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. | Enzymes / Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme |
| Agkistrodon piscivorus antivenin | Not Available | | A mixture of antibodies used to treat venomous snake bites from the Crotalinae family (pit vipers). | Antivenins |
| Albiglutide | 72970.0 C3232H5032N864O979S41 |  | A GLP-1 agonist used to manage type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues / Incretin Mimetics |
| Albumin Aggregated | Not Annotated | | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for... | Radioactive Diagnostic Agent |
| Albumin human | 66472.2 C2936H4624N786O889S41 |  | A purified form of human serum albumin used to replace lost albumin in patients with hypoalbuminemia, to treat hypovolemia and ascites, and as a part of some diagnostic imaging kits. | Blood Substitutes and Plasma Protein Fractions |
| Albumin iodinated I-125 serum | Not Annotated | | A radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume. | Radioactive Diagnostic Agent |
| Albumin iodinated I-131 serum | Not Annotated | | A radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume and other diagnostic purposes. | Radiopharmaceutical Activity |
| Albutrepenonacog alfa | 125000.0 C5077N7846O1588PS67 |  | A recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B. | Albumins / Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Drugs that are Mainly Renally Excreted / Enzyme Precursors / Enzymes and Coenzymes / Hemostatics / Protein Precursors / Proteins / Recombinant Proteins |
| Aldesleukin | 15314.8 C690H1115N177O202S6 |  | A recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma. | Interleukins |
| Alefacept | 51801.1 C2306H3594N610O694S26 |  | A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis. | Selective Immunosuppressants |
| Alemtuzumab | 145453.8 C6468H10066N1732O2005S40 |  | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. | Selective Immunosuppressants |
| Alglucerase | 55597.4 C2532H3854N672O711S16 |  | A form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. | Enzymes |
| Alglucosidase alfa | 105270.802 C4435H6739N1175O1279S32 |  | An acid alpha- glucosidase (GAA) derivative used as an enzyme replacement therapy for the treatment of Pompe disease in infants and pediatric patients caused by GAA deficiency. | Enzymes / Glucosidases / Glycogen Storage Disease Type II / Hydrolytic Lysosomal Glycogen-specific Enzyme |
| Alirocumab | 146000.0 C6472H9996N1736O2032S42 |  | A PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C). | Hypercholesterolemia, drug therapy / Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor |
| Alpha-1-proteinase inhibitor | 44324.5 C2001H3130N514O601S10 |  | A purified form of human alpha-1 proteinase inhibitor used to treat emphysema patients with associated alpha-1 proteinase inhibitor deficiency. | Proteinase Inhibitors |
| Alteplase | 59000.0 C2569H3928N746O781S40 |  | A recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli. | Enzymes |
| Amivantamab | 148000.0 | | An EGF and MET receptor targeted antibody indicated in the treatment of non-small cell lung cancer with an EGFR 20 exon insertion mutation. | Antineoplastic Agents, Immunological |
| Anacaulase | 23000.0 | | A mix of proteolytic enzymes indicated for eschar removal in adults with deep partial thickness and/or full-thickness thermal burns. | Administration, Topical / Cysteine Endopeptidases / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Enzymes / Enzymes and Coenzymes / Hydrolases / Peptide Hydrolases / Wound Healing |
Displaying drugs 1 - 25 of 403 in total